SCHEMBL10039102

SCHEMBL10039102

Cc1ccc(-c2nc(NS(=O)(=O)c3cccc4nonc34)sc2C)cc1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TASP1 Q9H6P5 2/20 1.00
POLB P06746 2/20 0.50
GFER P55789 1/20 0.50
KMT2A Q03164 6/20 0.49
MAPT P10636 4/20 0.49
ALDH1A1 P00352 4/20 0.49
MEN1 O00255 3/20 0.49
KDM1A O60341 1/20 0.46
PTPN2 P17706 3/20 0.46
PTPN1 P18031 3/20 0.46
PTPN5 P54829 3/20 0.46
HSPD1 P10809 2/20 0.46
HSPE1 P61604 2/20 0.46
TST Q16762 1/20 0.46
MAPK1 P28482 1/20 0.45
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ACLY P53396 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5244837 0.72 POLB (0.72) TASP1POLBGFERKMT2AMAPT
SCHEMBL5332821 0.70 POLB (0.68) TASP1POLBGFERKMT2AMAPT
SCHEMBL5246130 0.70 ALDH1A1 (0.69) TASP1POLBGFERKMT2AMAPT
SCHEMBL6392497 0.69 ALDH1A1 (0.75) TASP1POLBGFERKMT2AMAPT
SCHEMBL6397592 0.68 KMT2A (0.78) TASP1POLBGFERKMT2AMAPT
SCHEMBL5281422 0.68 KMT2A (0.66) TASP1POLBGFERKMT2AMAPT
SCHEMBL5244572 0.67 KMT2A (0.63) TASP1POLBGFERKMT2AMAPT
SCHEMBL5243746 0.67 KMT2A (0.64) POLBGFERKMT2AMAPTALDH1A1
SCHEMBL6393820 0.67 KMT2A (0.64) TASP1POLBGFERKMT2AMAPT
SCHEMBL14433266 0.66 KMT2A (0.76) POLBGFERKMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501811-B2 TASPASE1 inhibitors and their uses WASHINGTON UNIVERSITY (US) 2013-08-06 US disclosed
US-8501811-B2 TASPASE1 inhibitors and their uses WASHINGTON UNIVERSITY (US) 2013-08-06 US disclosed
US-20120015990-A1 TASPASE1 INHIBITORS AND THEIR USES THE WASHINGTON UNIVERSITY (US) 2012-01-19 US disclosed
US-20120015990-A1 TASPASE1 INHIBITORS AND THEIR USES THE WASHINGTON UNIVERSITY (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015990-A1 TASPASE1 INHIBITORS AND THEIR USES RNASE1, TASP1, PPA1 TASP1 2/4885POLB 604/4885GFER 3958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.